BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20083670)

  • 1. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection.
    Sivick KE; Schaller MA; Smith SN; Mobley HL
    J Immunol; 2010 Feb; 184(4):2065-75. PubMed ID: 20083670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of chronic Escherichia coli urinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence.
    Chamoun MN; Sullivan MJ; Goh KGK; Acharya D; Ipe DS; Katupitiya L; Gosling D; Peters KM; Sweet MJ; Sester DP; Schembri MA; Ulett GC
    FASEB J; 2020 Nov; 34(11):14572-14587. PubMed ID: 32901999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
    Billips BK; Forrestal SG; Rycyk MT; Johnson JR; Klumpp DJ; Schaeffer AJ
    Infect Immun; 2007 Nov; 75(11):5353-60. PubMed ID: 17724068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.
    Mao X; Guo H; Yao R; Bao L; Sun J; Bao Y; Guo B; Gao Y; Shi Y; Zhang H; Cui X
    J Ethnopharmacol; 2020 Oct; 260():112578. PubMed ID: 31962152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection.
    Zychlinsky Scharff A; Rousseau M; Lacerda Mariano L; Canton T; Consiglio CR; Albert ML; Fontes M; Duffy D; Ingersoll MA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31145099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group 3 Innate Lymphoid Cells Protect the Host from the Uropathogenic Escherichia coli Infection in the Bladder.
    Huang J; Fu L; Huang J; Zhao J; Zhang X; Wang W; Liu Y; Sun B; Qiu J; Hu X; Liu Z; Guo X
    Adv Sci (Weinh); 2022 Feb; 9(6):e2103303. PubMed ID: 35018740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE; Beasley FC; Olson J; Keller N; Shalwitz RA; Hannan TJ; Hultgren SJ; Nizet V
    PLoS Pathog; 2015 Apr; 11(4):e1004818. PubMed ID: 25927232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
    Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
    J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
    Patras KA; Ha AD; Rooholfada E; Olson J; Ramachandra Rao SP; Lin AE; Nizet V
    J Innate Immun; 2019; 11(6):481-495. PubMed ID: 31055580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.
    Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC
    J Immunol; 2012 Jan; 188(2):781-92. PubMed ID: 22184725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic
    Zhang Y; Zhang S; He Y; Sun Z; Cai W; Lv Y; Jiang L; Li Q; Zhu S; Li W; Ye C; Wu B; Xue Y; Chen H; Cai H; Chen T
    Front Cell Infect Microbiol; 2019; 9():457. PubMed ID: 31998663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.
    Hu F; Ding G; Zhang Z; Gatto LA; Hawgood S; Poulain FR; Cooney RN; Wang G
    Innate Immun; 2016 Jan; 22(1):9-20. PubMed ID: 26511057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide Domains Modulate Urovirulence.
    Aguiniga LM; Yaggie RE; Schaeffer AJ; Klumpp DJ
    Infect Immun; 2016 Nov; 84(11):3131-3140. PubMed ID: 27528276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.
    Ozer A; Altuntas CZ; Bicer F; Izgi K; Hultgren SJ; Liu G; Daneshgari F
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25663347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uropathogenic Escherichia coli as a model of host-parasite interaction.
    Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
    Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on Its Extra-Intestinal Virulence Status.
    Tourret J; Willing BP; Croxen MA; Dufour N; Dion S; Wachtel S; Denamur E; Finlay BB
    PLoS One; 2016; 11(4):e0153034. PubMed ID: 27096607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection.
    Ching CB; Gupta S; Li B; Cortado H; Mayne N; Jackson AR; McHugh KM; Becknell B
    Kidney Int; 2018 Jun; 93(6):1320-1329. PubMed ID: 29475562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.